For the Inventor, By the Inventor

Enter assignee name

Huntsville, AL, United States of America

Serina Therapeutics, Inc.

USPTO Granted Patents = 23

EPO Patents = 4

Trademarks = 4

Forward Citations = 110

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Michael David Bentley (23 out of 138 patents)

Kunsang Yoon (20 out of 25 patents)

Zhihao Fang (19 out of 47 patents)

4. Tacey Viegas (17 out of 41 patents)

5. J Milton Harris (14 out of 90 patents)

6. Randall Moreadith (10 out of 16 patents)

7. Rebecca Weimer (8 out of 14 patents)

8. Bekir Dizman (6 out of 7 patents)

9. Francesco Maria Veronese (3 out of 17 patents)

10. Michael Reif (2 out of 2 patents)

11. Anna Mero (1 out of 1 patent)

12. Rainer Jordan (1 out of 1 patent)

13. Rainer Jordon (1 out of 1 patent)

14. Robert J Sharpe (1 out of 2 patents)

15. Ribecca Weimer (0 patent)

23 patents: Sort by Forward Citations

1. 12233132 - Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same (2025-02-25),

2. 11944618 - Subcutaneous delivery of polymer conjugates of therapeutic agents (2024-04-02),

3. 11925689 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2024-03-12),

4. 11766432 - Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same (2023-09-26),

5. 11298350 - Subcutaneous delivery of polymer conjugates of therapeutics agents (2022-04-12),

6. 11224595 - Subcutaneous delivery of poly(oxazoline) polymer conjugates (2022-01-18),

7. 11213588 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2022-01-04),

8. 11065340 - Polyoxazoline antibody drug conjugates (2021-07-20),

9. 10864276 - Activated polyoxazolines and conjugates and compositions comprising the same (2020-12-15),

10. 10314837 - Subcutaneous delivery of poly(oxazoline) polymer conjugates (2019-06-11),

11. 10166294 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2019-01-01),

12. 10086084 - Activated polyoxazolines and conjugates and compositions comprising the same (2018-10-02),

13. 10071168 - Polyoxazoline antibody drug conjugates (2018-09-11),

14. 9284411 - Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds (2016-03-15),

15. 9169354 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2015-10-27),

Company Overview

Serina Therapeutics, Inc. is a biotechnology company based in Huntsville, Alabama, focused on developing innovative drug delivery systems. The company specializes in the design and manufacture of polymer-based formulations aimed at enhancing the efficacy and safety of therapeutic agents. With a commitment to advancing healthcare solutions, Serina Therapeutics leverages its expertise in polymer science and drug formulation to address unmet medical needs across various therapeutic areas, including oncology and chronic diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#17 in Huntsville, AL

#59 in Alabama

#14,428 in US

#27,685 in the World

Huntsville, AL, United States of America

Serina Therapeutics, Inc.

Forward Citations = 110

14 inventors:

Michael David Bentley (23 out of 138 patents)

Kunsang Yoon (20 out of 25 patents)

Zhihao Fang (19 out of 47 patents)

4. Tacey Viegas (17 out of 41 patents)

5. J Milton Harris (14 out of 90 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Serina Therapeutics, Inc.. Retrieved from https://idiyas.com/company/serina-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…